Replies to post #8391 on Novavax Inc (NVAX)

[TucsonPhil]

I agree. A lot of things SHOULD happen, but don't, for unknown reasons. I believe the late approval will hit Q3 earnings and we will not see significant jump until next Q. Unfortunately, many people will need to get sick, or die, in the coming months, and the media will need to jump on the numbers as a story to lead with, before the public embraces getting another jab.

Novavax marketing will need to improve, if they are to have the public request their vaccine, since it seems like pharmacists will just give the "preferred" prick, and we all know which ones those are.